- Home
- ZENV vs PMVP Comparison
ZENV vs PMVP Comparison
Compare ZENV & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- PMVP
- Stock Information
- Founded
- ZENV 2005
- PMVP 2013
- Country
- ZENV Brazil
- PMVP United States
- Employees
- ZENV N/A
- PMVP N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ZENV Technology
- PMVP Health Care
- Exchange
- ZENV Nasdaq
- PMVP Nasdaq
- Market Cap
- ZENV 79.7M
- PMVP 76.8M
- IPO Year
- ZENV 2021
- PMVP 2020
- Fundamental
- Price
- ZENV $1.43
- PMVP $1.42
- Analyst Decision
- ZENV
- PMVP Strong Buy
- Analyst Count
- ZENV 0
- PMVP 1
- Target Price
- ZENV N/A
- PMVP $5.00
- AVG Volume (30 Days)
- ZENV 104.7K
- PMVP 949.9K
- Earning Date
- ZENV 11-17-2025
- PMVP 11-06-2025
- Dividend Yield
- ZENV N/A
- PMVP N/A
- EPS Growth
- ZENV N/A
- PMVP N/A
- EPS
- ZENV N/A
- PMVP N/A
- Revenue
- ZENV $201,426,369.00
- PMVP N/A
- Revenue This Year
- ZENV $6.49
- PMVP N/A
- Revenue Next Year
- ZENV $3.82
- PMVP N/A
- P/E Ratio
- ZENV N/A
- PMVP N/A
- Revenue Growth
- ZENV 24.80
- PMVP N/A
- 52 Week Low
- ZENV $1.02
- PMVP $0.81
- 52 Week High
- ZENV $3.03
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- ZENV 54.00
- PMVP 50.54
- Support Level
- ZENV $1.26
- PMVP $1.36
- Resistance Level
- ZENV $1.48
- PMVP $1.49
- Average True Range (ATR)
- ZENV 0.08
- PMVP 0.08
- MACD
- ZENV 0.02
- PMVP 0.01
- Stochastic Oscillator
- ZENV 90.91
- PMVP 57.41
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.